DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 967 filers reported holding DANAHER CORPORATION in Q2 2015. The put-call ratio across all filers is 0.93 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $10,000 | -88.1% | 113 | -88.5% | 0.02% | -83.9% |
| Q3 2017 | $84,000 | -1.2% | 983 | -2.8% | 0.15% | +8.8% |
| Q2 2017 | $85,000 | -13.3% | 1,011 | -12.2% | 0.14% | -2.1% |
| Q1 2017 | $98,000 | +8.9% | 1,151 | -0.8% | 0.14% | -6.0% |
| Q4 2016 | $90,000 | -4.3% | 1,160 | -3.1% | 0.15% | -9.7% |
| Q3 2016 | $94,000 | -27.7% | 1,197 | -6.8% | 0.16% | -20.3% |
| Q2 2016 | $130,000 | +22.6% | 1,284 | +15.3% | 0.21% | +31.0% |
| Q1 2016 | $106,000 | 0.0% | 1,114 | -2.8% | 0.16% | +5.3% |
| Q4 2015 | $106,000 | +7.1% | 1,146 | -1.3% | 0.15% | +8.7% |
| Q3 2015 | $99,000 | +7.6% | 1,161 | +8.1% | 0.14% | +30.2% |
| Q2 2015 | $92,000 | +1.1% | 1,074 | 0.0% | 0.11% | -2.8% |
| Q1 2015 | $91,000 | +21.3% | 1,074 | +23.3% | 0.11% | +25.3% |
| Q4 2014 | $75,000 | +82.9% | 871 | +59.8% | 0.09% | +64.2% |
| Q3 2014 | $41,000 | – | 545 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |